High-risk fund adjusts organization to stay on top of its game

Fresh off of promoting several team members to partners, life science venture capital fund HealthCap's founder Björn Odlander talks to AMWatch about new strategy developments and why pension funds and endowments keep returning to the firm's high-risk family of VC funds. He is, however, tight-lipped about past performance.

Dr. Björn Odlander, founder and partner of Healthcap | Photo: PR / Healthcap/Dan Coleman AB

Swedish venture capital firm HealthCap specializes in investing in companies that try to find and develop medical solutions to serious diseases such as cancer and genetic diseases.

It's a strategy the firm has had for a long time, and the decision was recently made to expand the team and promote several new partners to advance the efforts.

Five people have boosted the senior team: four of them were promoted from other roles, and the new hire that started in September completes the quintet. Most importantly, HealthCap has promoted Mårten Steen to co-managing partner alongside founder Björn Odlander.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Why do Nordic funds have so few female portfolio managers?

Only 16 percent of fund managers in Sweden are women. The figure is 11 percent in Finland, while just 6 percent of fund managers in Denmark and Norway are female. AMWatch has talked to four Nordic women in finance in search of answers regarding this imbalance and to hear about their career experiences. 

Further reading

Related articles

Trial banner

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch